T1	Participants 602 656	2416 infants were stratified according to birth weight
T2	Participants 770 783	control group
T3	Participants 714 753	to an intravenous immune globulin group
T4	Participants 796 811	Control infants
T5	Participants 1048 1079	infants weighing 1001 to 1500 g
T6	Participants 938 945	Infants
T7	Participants 1199 1221	infants weighed 1800 g
T8	Participants 1385 1408	439 of the 2416 infants
T9	Participants 1425 1472	208 (17.3 percent) in the immune globulin group
T10	Participants 1477 1516	231 (19.1 percent) in the control group
T11	Participants 1645 1688	recipients and 17.2 percent of the controls
T12	Participants 1789 1822	17.8 percent in the control group
